Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

FDA: Cybersecurity is an ever-present risk for medical devices

US regulator issues new guidance for manufacturers

US FDA (Food and Drug Administration)

US regulators have issued new cybersecurity guidance for medical device manufacturers that they say will provide an 'all-out, life cycle approach' to the issue. 

The FDA says there is an increased and ever-present risk of security breaches and, updating the draft guidance it issued last year, confirms manufacturers should consider cybersecurity through the total product life cycle of their devices.

Last Autumn Johnson & Johnson is thought to have become the first firm to sound the alarm about a cyber vulnerability.

In October the manufacturer was forced to issue a warning to patients using one of its insulin pumps that the device could be attacked, potentially allowing a hacker to overdose patients with insulin.

Suzanne Schwartz, FDA's associate director for science and strategic partnerships at the Center for Devices and Radiological Health, writes: “In today's world of medical devices that are connected to a hospital's network or even a patient's own internet service at home, we see significant technological advances in patient care and, at the same time, an increase in the risk of cybersecurity breaches that could affect a device's performance and functionality.”

The regulator wants manufacturers to build in cybersecurity controls right from when they design and develop a device and to then 'continuously monitor and address' cybersecurity concerns once a device starts being used by patients.

“With this guidance, we now have an outline of steps the FDA recommends manufacturers take to remain vigilant and continually address the cybersecurity risks of marketed medical devices,” Schwartz added.

• Read: The FDA's post-marketing management of cybersecurity in medical devices guidance

9th January 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics